Immutep(IMMP)
搜索文档
Immutep (IMMP) presents TACTI-002 data at ASCO 2022 - Slideshow
2022-06-11 01:02
| --- | --- | --- | |-------|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | | | | | | | | | for | Global Webcast Slides TACTI-002 data presented at ASCO 2022 | | | Webcast Details | | | | Date & Time: | 5.00 pm CDT (Chicago) Monday 6 June 2022/ | | | Speakers: | 8.00 am AEST (Sydney) Tuesday 7 June 2022 Immutep CEO Marc Voigt, CMO/C ...
Immutep (IMMP) Investor Presentation - Slideshow
2022-06-03 23:51
| --- | --- | --- | |-------|-------------------------------------------------------------------------------------|-------| | | | | | | | | | | The global leader in developing LAG-3 therapeutics Corporate Presentation May 2022 | | | | | | (ASX: IMM, NASDAQ: IMMP) Notice: Forward-Looking Statements The purpose of the presentation is to provide an update of the business of Immutep Limited ACN 009 237 889 (ASX:IMM; NASDAQ:IMMP). These slides have been prepared as a presentation aid only and the information the ...
Immutep (IMMP) To Host Eftilagimod Alpha Clinical Development Update Global - Slideshow
2019-04-06 04:09
| --- | --- | |-------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------| | | | | Date & Time Eftilagimod | : Wednesday, April 3, 2019, 7:45am Australian Eastern Standard Time Alpha Clinical Development Update and New Data from Ongoing Melanoma Study | | Register | Tuesday, April 2, 2019, 4:45pm US Eastern Daylight Time : Interested investors can register via the following link to the webcast we ...
Immutep Limited (IMMP) To Present At Oppenheimer 29th Annual Healthcare Conference - Slideshow
2019-03-19 23:15
| --- | --- | --- | |-------|-------|-------| | | | | | | | | | | | | | | | | Notice: Forward Looking Statements The purpose of the presentation is to provide an update of the business of Immutep Limited ACN 009 237 889 (ASX:IMM; NASDAQ:IMMP). These slides have been prepared as a presentation aid only and the information they contain may require further explanation and/or clarification. Accordingly, these slides and the information they contain should be read in conjunction with past and future announcement ...